(Q43336624)

English

Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: similar therapeutical effects from heterogeneous pharmacological targets.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22093116%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: similar therapeutical effects from heterogeneous pharmacological targets (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22093116%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22093116%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Pere Clavé

1

1 reference

Europe PubMed Central

19 November 2017

publication date

1 December 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22093116%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Neurogastroenterology and Motility

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22093116%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22093116%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22093116%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1051-1055

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22093116%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Systematic review: the efficacy of treatments for irritable bowel syndrome--a European perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Serotonergic modulating drugs for functional gastrointestinal diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

AGA technical review on irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Role of motility in chronic diarrhoea.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Effects of excitatory and inhibitory neurotransmission on motor patterns of human sigmoid colon in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Effect of otilonium bromide on contractile patterns in the human sigmoid colon

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Ligand-gated ion channels in the enteric nervous system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01808.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43336624&oldid=1605299501"